Immunological Efficacy of a Three-Dose Schedule of Hepatitis A Vaccine in HIV-Infected Adults: HEPAVAC StudyOdile Launay, David Rey, Sophie Grabar et al.|JAIDS Journal of Acquired Immune Deficiency Syndromes|2008Cited by 71
Safety and efficacy of doravirine as first-line therapy in adults with HIV-1: week 192 results from the open-label extensions of the DRIVE-FORWARD and DRIVE-AHEAD phase 3 trialsChloe Orkin, Christine Katlama, Khuanchai Supparatpinyo et al.|The Lancet HIV|2023Cited by 31